PCAS 2015 earnings up sharply
Longjumeau, February 18th, 2016
Earnings
As of 31 December 2015, the PCAS Group had generated consolidated net sales of €179.1 million up by 7.7 % compared to the same period for the previous financial year (+3.8 % at a constant exchange rate).
EBITDA is up 48 % at €27.0 million, against €18.3 million in 2014, a margin of 15.1 % against 11.0 % in 2014. Current operating income stands at €15.6 million, up by 95.4 % compared to 2014, driven by the increase in volumes and favourable exchange rate parity.
After accounting for non-recurring income of €2.9 million net of income and higher finance charges in the period, the PCAS Group's net income stands at €9.0 million in 2015, against €2.5 million in 2014.
Net debt continued to fall, down to €34.7 million as of 31 December 2015 against €48.0 million as of 31 December 2014.
Outlook for the current year
In 2016 the PCAS group forecasts an increase in sales, excluding external growth, in all its operations, which should lead to a new improvement in the results.
The PCAS group has the necessary resources to continue implementing its ambitious investment program and is considering external growth opportunities.
Dividend
Under those circumstances, the Board of Directors will ask the next Shareholder's Meeting to approve payment of a dividend of 0.12 Euros per share (including the interim dividend of 0.06 Euros per share paid in September 2015).
| Next meeting: | |
| 2016 Shareholder's Meeting in Longjumeau at 10 a.m. on April 21, 2016 |
About PCAS (Euronext Paris: BCP, eligible for the PEA-PME plan)
PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €179,1 million in 2015 and employs nearly 900 people in six countries.
For more information about PCAS: www.pcas.com
| PCAS | NewCap |
| Vincent Touraille / Eric Moissenot PCAS | Emmanuel Huynh NewCap Financial Communication & investors relations |
| Tel. : +33 1 69 79 61 32 www.pcas.com | Tel. : +33 1 44 71 94 94 pcas@newcap.eu |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PCAS via Globenewswire
